A leading Contract Research Organisation (CRO) specializing in early-phase clinical trials for pharmaceutical and biotechnology companies.
About
Hammersmith Medicines Research (HMR) is a UK-based Contract Research Organisation (CRO) that specializes in conducting Phase 1 and early Phase 2 clinical trials. Founded in 1993, HMR is one of the largest early-phase CROs in Europe, offering a full range of services from study design to final report. They work with pharmaceutical and biotechnology companies worldwide, focusing on safety, ethical conduct, and high-quality data.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does HMR London do?
Hammersmith Medicines Research (HMR) is a UK-based Contract Research Organisation (CRO) that specializes in conducting Phase 1 and early Phase 2 clinical trials. Founded in 1993, HMR is one of the largest early-phase CROs in Europe, offering a full range of services from study design to final report. They work with pharmaceutical and biotechnology companies worldwide, focusing on safety, ethical conduct, and high-quality data.
Where is HMR London headquartered?
HMR London is headquartered in London, United Kingdom.
When was HMR London founded?
HMR London was founded in 1993.
What industry does HMR London operate in?
HMR London operates in Pharmaceutical Research & Development, Clinical Trials, Drug Discovery, Biotechnology, Contract Research Organization.